Inicio・Lista de Acciones・Repligen Corp

Repligen Corp

Cerrado

SectorSanidad

167.35 -1.29

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

166.41

Máximo

167.54

Métricas clave
By Trading Economics
Ingresos	-3.3M 5M
Ventas	9.9M 204M
P/B Media del Sector	244.568 56.659
BPA	0.54
Margen de beneficios	2.453
Empleados	2,000
EBITDA	-35M -2.4M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+7.2% upside

Dividendos
By Acuity
Próximas Ganancias	27 oct 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	2.8B 10B
Apertura anterior	168.64
Cierre anterior	167.35

Repligen Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

2 sept 2026, 19:26 UTC

Repligen Corp shares are higher during Wednesday's session, reaching a session high earlier today. The stock shows resilience amid broader market geopolitical tensions.

1 sept 2026, 20:01 UTC

Repligen Corp shares are lower today, continuing a decline from Monday's close amid rising oil prices and inflation concerns affecting market conditions.

31 ago 2026, 21:02 UTC

Repligen Corp shares are lower in after-market hours amid broader economic concerns and hawkish comments from Fed Chair Kevin Warsh on inflation and interest rates.

28 ago 2026, 23:01 UTC

Repligen Corp shares are higher in after-market hours, reflecting strong momentum and positioning near the upper end of their one-month trading range.

26 ago 2026, 19:46 UTC

News

Repligen Corp shares are lower during Wednesday's session amid broader market volatility and persistent inflationary pressures reflected in recent PCE data.

25 ago 2026, 22:01 UTC

Repligen Corp shares are lower in after-market trading, reflecting broader market caution ahead of key economic events and a drop in consumer confidence.

24 ago 2026, 19:36 UTC

Repligen Corp shares are higher today, continuing an upward trend since Friday. The stock showed volatility, peaking earlier in the session.

21 ago 2026, 22:31 UTC

Correlated Moves

Repligen Corp's after-market performance is roughly flat, reflecting a slight decline since Friday's close amid broader market weakness in the life sciences sector.

20 ago 2026, 19:51 UTC

Repligen Corp is gaining during Thursday's session, supported by strong movement in the Life Sciences Tools & Services sub-sector. Shares pulled back earlier but have advanced.

19 ago 2026, 20:02 UTC

Repligen Corp is advancing sharply, supported by gains in the Life Sciences Tools & Services sub-sector. The stock remains above its 20-day moving average.

18 ago 2026, 19:36 UTC

Repligen Corp shares are declining, continuing a downward trend since Monday. Broader market sentiment remains cautious amid rising treasury yields and inflation concerns.

14 ago 2026, 19:16 UTC

Repligen Corp shares are lower today amid a lack of specific news. Investor sentiment is cautious following a decline in U.S. retail sales.

13 ago 2026, 22:01 UTC

Repligen Corp shares are lower in after-market hours, dropping from a brief high. The price remains above its 20-day moving average.

12 ago 2026, 19:36 UTC

Repligen Corp shares are higher today amid broader market optimism following a modest increase in the core Consumer Price Index. No specific company news was identified.

11 ago 2026, 20:01 UTC

Repligen Corp shares are higher today, reflecting strong performance amid routine trading. The stock remains above its 20-day moving average.

10 ago 2026, 23:16 UTC

Repligen Corp shares are trading higher in after-market hours. The stock remains near the upper end of its one-month trading range.

7 ago 2026, 22:01 UTC

Repligen Corp shares are higher in after-market trading, continuing a trend of six consecutive sessions. Broader equity gains follow weaker employment data easing rate hike concerns.

6 ago 2026, 20:02 UTC

Repligen Corp shares are higher today, continuing gains from Wednesday. No specific company news was identified to explain the movement.

5 ago 2026, 20:02 UTC

Correlated Moves

Repligen Corp shares are higher today, bolstered by gains in Charles River Laboratories and positive sentiment in the life sciences sector.

4 ago 2026, 19:56 UTC

Repligen Corp shares are higher today, reflecting broader market strength amid a significant decline in crude oil prices. The stock is near its one-month range's upper end.

31 jul 2026, 20:02 UTC

Repligen Corp shares are lower today amid broader market pressures and rising US Treasury yields. The stock reached a session low earlier.

30 jul 2026, 21:02 UTC

Repligen Corp shares are higher in after-market trading, buoyed by positive investor sentiment amid a focus on corporate earnings and broader market trends.

29 jul 2026, 16:12 UTC

Repligen Corp shares are lower Wednesday, breaking a trend of higher daily closes. Broader market conditions reflect rising crude oil prices and inflation concerns.

28 jul 2026, 23:21 UTC

Repligen Corp shares are higher in after-market trading, reflecting strong momentum and trading near the upper end of its one-month range.

27 jul 2026, 16:26 UTC

News

Repligen Corporation shares are lower as the company approaches its Q2 earnings report, with analysts projecting 10.7% revenue growth. Current price is $131.96.

24 jul 2026, 19:06 UTC

News

Repligen Corp is under scrutiny as a stock to avoid, with concerns over its $763.3 million revenue and declining operating margins. Shares are trading lower today.

22 jul 2026, 19:25 UTC

News

Event

Social Media

Repligen Corp is acquiring BioLife Solutions for about $1.5 billion, offering $11.25 in cash and stock, with a projected $20 million in synergies.

21 jul 2026, 22:56 UTC

Repligen Corp shares are higher in after-market trading, despite a recent trend of lower closes. Broader market sentiment may be influenced by the Nikkei 225 surge.

20 jul 2026, 18:06 UTC

Repligen Corp shares are higher today, reflecting positive market sentiment despite earlier intraday fluctuations. No specific news was identified to explain the movement.

Comparación entre iguales

Cambio de precio

Repligen Corp previsión

Precio Objetivo

By TipRanks

7.2% repunte

Estimación a 12 Meses

Media 179.67 USD 7.2%

Máximo 207 USD

Mínimo 145 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Repligen Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

11 ratings

Comprar

Mantener

Vender

De acuerdo con 11 analistas que ofrecen calificaciones bursátiles a para Repligen Corp Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.